azacitidine

Italy

Drugs containing this active substance

  • AZACITIDINE ACCORD

    It is used to treat adults with acute myeloid leukemia (AML) to keep the disease under control. The injectable suspension version is also used for high-risk myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML).

    Form: powder for preparation of injectable suspension

    Active substance Dosage
    azacitidine -

    ATC: L01BC07

    Manufacturer: ACCORD HEALTHCARE, S.L.U.

  • AZACITIDINE BETAPHARM

    It is used in adults to treat three types of diseases that affect the bone marrow: high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).

    Form: powder for preparation of injectable suspension

    Active substance Dosage
    azacitidine -

    ATC: L01BC07

    Manufacturer: BETAPHARM ARZNEIMITTEL GMBH

  • AZACITIDINE KABI

    It is used in adults who are not candidates for a stem cell transplant to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).

    Form: powder for preparation of injectable suspension

    Active substance Dosage
    azacitidine -

    ATC: L01BC07

    Manufacturer: FRESENIUS KABI DEUTSCHLAND GMBH

  • AZACITIDINE MYLAN

    It is used in adults who are not candidates for a stem cell transplant to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). These diseases affect the bone marrow and interfere with the production of blood cells.

    Form: powder for preparation of injectable suspension

    Active substance Dosage
    azacitidine -

    ATC: L01BC07

    Manufacturer: MYLAN PHARMACEUTICALS LIMITED

  • AZACITIDINE SANDOZ

    It is used in adults who are not candidates for a stem cell transplant to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). These diseases affect the bone marrow and interfere with the production of blood cells.

    Form: powder for preparation of injectable suspension

    Active substance Dosage
    azacitidine -

    ATC: L01BC07

    Manufacturer: SANDOZ S.P.A.

  • AZACITIDINE SEACROSS

    It is used in adults who are not candidates for stem cell transplantation for the treatment of high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).

    Form: powder for preparation of injectable suspension

    Active substance Dosage
    azacitidine -

    ATC: L01BC07

    Manufacturer: SEACROSS PHARMA (EUROPE) LTD

  • AZACITIDINE TILLOMED

    It is used in adults who cannot receive a stem cell transplant to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). These diseases affect the bone marrow and can affect the production of blood cells.

    Form: powder for preparation of injectable suspension

    Active substance Dosage
    azacitidine -

    ATC: L01BC07

    Manufacturer: TILLOMED ITALIA SRL

  • ONUREG

    Onureg is used in adults to treat acute myeloid leukemia (AML), a type of cancer that affects the bone marrow, with the aim of controlling the disease.

    Form: tablets, film-coated

    Active substance Dosage
    azacitidine -

    ATC: L01BC07

    Manufacturer: BRISTOL-MYERS SQUIBB PHARMA EEIG

  • VIDAZA

    It is used in adults who cannot receive a stem cell transplant to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).

    Form: powder for preparation of injectable suspension

    Active substance Dosage
    azacitidine -

    ATC: L01BC07

    Manufacturer: BRISTOL-MYERS SQUIBB PHARMA EEIG